MetaADEDB 2.0 @ LMMD
Metformin
(OETHQSJEHLVLGH-UHFFFAOYSA-N)
Structure
SMILES
CN(C(=N)N=C(N)N)C.Cl
Molecular Formula:
C4H12ClN5
Molecular Weight:
165.625
Log P:
1.0585
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
4
TPSA:
91.49
CAS Number(s):
1115-70-4
Synonym(s)
1.
Metformin
2.
Dimethylguanylguanidine
3.
Dimethylbiguanidine
4.
Glucophage
5.
Metformin HCl
6.
Metformin Hydrochloride
7.
HCl, Metformin
8.
Hydrochloride, Metformin
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood glucose increasedFAERS: 580
Canada Vigilance: 7
Canada Vigilance
US FAERS
2VomitingFAERS: 507
Canada Vigilance: 1
Canada Vigilance
US FAERS
3NauseaFAERS: 481
Canada Vigilance: 7
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 479
Canada Vigilance: 6
Canada Vigilance
US FAERS
5Acute kidney injuryFAERS: 388US FAERS
6Toxicity to various agentsFAERS: 388
Canada Vigilance: 2
Canada Vigilance
US FAERS
7Metabolic acidosisFAERS: 347US FAERS
8HypotensionFAERS: 336
Canada Vigilance: 1
Canada Vigilance
US FAERS
9MalaiseFAERS: 242
Canada Vigilance: 1
Canada Vigilance
US FAERS
10OverdoseFAERS: 197
Canada Vigilance: 2
Canada Vigilance
US FAERS
11Abdominal PainFAERS: 180
Canada Vigilance: 5
Canada Vigilance
US FAERS
12Suicide attemptFAERS: 180US FAERS
13Abdominal discomfortFAERS: 176
Canada Vigilance: 6
Canada Vigilance
US FAERS
14ShockFAERS: 174US FAERS
15Cardiac ArrestFAERS: 159US FAERS
16DehydrationFAERS: 159
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Blood creatinine increasedFAERS: 144US FAERS
18Pharmaceutical product complaintFAERS: 138US FAERS
19DizzinessFAERS: 136
Canada Vigilance: 2
Canada Vigilance
US FAERS
20Completed SuicideFAERS: 125US FAERS
21FatigueFAERS: 122
Canada Vigilance: 2
Canada Vigilance
US FAERS
22Diabetes mellitus inadequate controlFAERS: 113US FAERS
23HeadacheFAERS: 105
Canada Vigilance: 5
Canada Vigilance
US FAERS
24HypersensitivityFAERS: 105US FAERS
25Product substitution issueFAERS: 105
Canada Vigilance: 1
Canada Vigilance
US FAERS
26AstheniaFAERS: 101
Canada Vigilance: 1
Canada Vigilance
US FAERS
27Weight decreasedFAERS: 100US FAERS
28Blood glucose decreasedFAERS: 96US FAERS
29Drug level increasedFAERS: 93US FAERS
30Myocardial InfarctionFAERS: 92
Canada Vigilance: 1
Canada Vigilance
US FAERS
31Adverse eventFAERS: 78US FAERS
32Blood glucose abnormalFAERS: 76US FAERS
33Feeling abnormalFAERS: 68
Canada Vigilance: 1
Canada Vigilance
US FAERS
34Medication residue presentFAERS: 68US FAERS
35Product use in unapproved indicationFAERS: 66US FAERS
36UrticariaFAERS: 66US FAERS
37AnuriaFAERS: 65US FAERS
38SomnolenceFAERS: 65
Canada Vigilance: 1
Canada Vigilance
US FAERS
39FlatulenceFAERS: 62
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Product quality issueFAERS: 62US FAERS
41Amylase increasedFAERS: 61US FAERS
42AlopeciaFAERS: 60US FAERS
43Medication ErrorFAERS: 59US FAERS
44Blood glucose fluctuationFAERS: 57US FAERS
45Maternal exposure during pregnancyFAERS: 55US FAERS
46DysgeusiaFAERS: 54US FAERS
47PainFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Respiratory FailureFAERS: 53US FAERS
49Medication residueFAERS: 51US FAERS
50MyalgiaFAERS: 51US FAERS
51Drug exposure during pregnancyFAERS: 50US FAERS
52Chest PainFAERS: 49
Canada Vigilance: 2
Canada Vigilance
US FAERS
53PruritusFAERS: 48US FAERS
54SepsisFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
55LethargyFAERS: 47US FAERS
56PneumoniaFAERS: 42US FAERS
57TachycardiaFAERS: 42US FAERS
58AgitationFAERS: 41US FAERS
59Cerebrovascular accidentFAERS: 40US FAERS
60Incorrect dose administeredFAERS: 40US FAERS
61PregnancyFAERS: 39US FAERS
62Mental status changesFAERS: 38US FAERS
63PancreatitisFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
64AcidosisFAERS: 36US FAERS
65DyspepsiaFAERS: 36US FAERS
66Depressed Level of ConsciousnessFAERS: 35US FAERS
67Septic ShockFAERS: 35US FAERS
68BradycardiaFAERS: 34US FAERS
69ConstipationFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
70TremorFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
71Therapeutic response unexpected with drug substitutionFAERS: 32US FAERS
72Back PainFAERS: 31US FAERS
73HepatotoxicityFAERS: 31US FAERS
74Acute myocardial infarctionFAERS: 29US FAERS
75PalpitationsFAERS: 29US FAERS
76Blood urea increasedFAERS: 28US FAERS
77Drug toxicityFAERS: 28US FAERS
78PoisoningFAERS: 28US FAERS
79General physical health deteriorationFAERS: 27US FAERS
80Urinary tract infectionFAERS: 27US FAERS
81Blood potassium increasedFAERS: 26US FAERS
82DisorientationFAERS: 26US FAERS
83Atrial FibrillationFAERS: 25US FAERS
84AngioedemaFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Drug abuseFAERS: 24US FAERS
86Live BirthFAERS: 24US FAERS
87ArthralgiaFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Drug level above therapeuticFAERS: 23US FAERS
89DysarthriaFAERS: 23US FAERS
90GastroenteritisFAERS: 22US FAERS
91Visual ImpairmentFAERS: 22US FAERS
92ErythemaFAERS: 21US FAERS
93Diabetic KetoacidosisFAERS: 20US FAERS
94Product taste abnormalFAERS: 20US FAERS
95Exposure via ingestionFAERS: 19US FAERS
96GastritisFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
97SyncopeFAERS: 19US FAERS
98VertigoFAERS: 19US FAERS
99Leukocytoclastic vasculitisFAERS: 18US FAERS
100Alanine Aminotransferase IncreasedFAERS: 17US FAERS
101Blood creatine phosphokinase increasedFAERS: 17US FAERS
102ChillsFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
103Drug dispensing errorFAERS: 17US FAERS
104LeukocytosisFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
105MydriasisFAERS: 17US FAERS
106Oxygen consumption decreasedFAERS: 17US FAERS
107Unresponsive to stimuliFAERS: 17US FAERS
108Wrong technique in product usage processFAERS: 17US FAERS
109treatment failureFAERS: 17US FAERS
110HyperventilationFAERS: 16US FAERS
111Memory impairmentFAERS: 16US FAERS
112SoporFAERS: 16US FAERS
113Unevaluable eventFAERS: 16US FAERS
114Chest discomfortFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
115Diabetes MellitusFAERS: 15US FAERS
116FlushingFAERS: 15US FAERS
117InfectionFAERS: 15US FAERS
118Intentional drug misuseFAERS: 15US FAERS
119KetoacidosisFAERS: 15US FAERS
120NephrolithiasisFAERS: 15US FAERS
121Product use issueFAERS: 15US FAERS
122jaundiceFAERS: 15US FAERS
123AmnesiaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Aspartate Aminotransferase IncreasedFAERS: 14US FAERS
125Blood pH decreasedFAERS: 14US FAERS
126Blood sodium decreasedFAERS: 14US FAERS
127Joint swellingFAERS: 14US FAERS
128OliguriaFAERS: 14US FAERS
129Respiratory distressFAERS: 14US FAERS
130nervous system disorderFAERS: 14US FAERS
131Accidental overdoseFAERS: 13US FAERS
132Altered state of consciousnessFAERS: 13US FAERS
133AphasiaFAERS: 13US FAERS
134BlindnessFAERS: 13US FAERS
135DeliriumFAERS: 13US FAERS
136EructationFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
137Peripheral swellingFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
138Pulmonary EmbolismFAERS: 13US FAERS
139ThrombocytopeniaFAERS: 13US FAERS
140Blood chloride decreasedFAERS: 12US FAERS
141Burning sensationFAERS: 12US FAERS
142Cleft PalateFAERS: 12US FAERS
143ColitisFAERS: 12US FAERS
144Deep Vein ThrombosisFAERS: 12US FAERS
145Disseminated Intravascular CoagulationFAERS: 12US FAERS
146Drug dose omissionFAERS: 12US FAERS
147DysenteryFAERS: 12US FAERS
148HepatitisFAERS: 12US FAERS
149Respiratory arrestFAERS: 12US FAERS
150RetchingFAERS: 12US FAERS
151Angina PectorisFAERS: 11US FAERS
152AnxietyFAERS: 11US FAERS
153Blood potassium decreasedFAERS: 11US FAERS
154Coma scale abnormalFAERS: 11US FAERS
155Gastrointestinal stoma complicationFAERS: 11US FAERS
156Intentional product misuseFAERS: 11US FAERS
157Product formulation issueFAERS: 11US FAERS
158TinnitusFAERS: 11US FAERS
159Visual disturbanceFAERS: 11US FAERS
160Anaphylactic shockFAERS: 10US FAERS
161AnorexiaFAERS: 10US FAERS
162Cholestatic liver injuryFAERS: 10US FAERS
163HoloprosencephalyFAERS: 10US FAERS
164PolyuriaFAERS: 10US FAERS
165Product solubility abnormalFAERS: 10US FAERS
166Sinus TachycardiaFAERS: 10US FAERS
167ThrombosisFAERS: 10US FAERS
168AnhidrosisFAERS: 9US FAERS
169Blood magnesium decreasedFAERS: 9US FAERS
170CholelithiasisFAERS: 9US FAERS
171CholestasisFAERS: 9US FAERS
172Diabetic NephropathyFAERS: 9US FAERS
173Drug prescribing errorFAERS: 9US FAERS
174EpistaxisFAERS: 9US FAERS
175Feeling ColdFAERS: 9US FAERS
176Gastrointestinal sounds abnormalFAERS: 9US FAERS
177Latent Autoimmune Diabetes in AdultsFAERS: 9US FAERS
178MalabsorptionFAERS: 9US FAERS
179No adverse eventFAERS: 9US FAERS
180PancytopeniaFAERS: 9US FAERS
181PneumoperitoneumFAERS: 9US FAERS
182RhabdomyolysisFAERS: 9US FAERS
183StillbirthFAERS: 9US FAERS
184SwellingFAERS: 9US FAERS
185VasculitisFAERS: 9US FAERS
186Vasoplegia syndromeFAERS: 9US FAERS
187Accidental exposureFAERS: 8US FAERS
188AsthmaFAERS: 8US FAERS
189Blood phosphorus increasedFAERS: 8US FAERS
190ChokingFAERS: 8US FAERS
191Disease ProgressionFAERS: 8US FAERS
192Distributive shockFAERS: 8US FAERS
193Gastric ulcerFAERS: 8US FAERS
194Hepatorenal SyndromeFAERS: 8US FAERS
195HypoxiaFAERS: 8US FAERS
196Impaired work abilityFAERS: 8US FAERS
197InflammationFAERS: 8US FAERS
198NervousnessFAERS: 8US FAERS
199Pancreatic carcinomaFAERS: 8US FAERS
200PolydactylyFAERS: 8US FAERS
201Poor peripheral circulationFAERS: 8US FAERS
202PyelonephritisFAERS: 8US FAERS
203Skinfold measurementFAERS: 8US FAERS
204Abdominal tendernessFAERS: 7US FAERS
205Blood urine presentFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
206CataractFAERS: 7US FAERS
207Creatinine renal clearance decreasedFAERS: 7US FAERS
208DiscomfortFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
209Drug administration errorFAERS: 7US FAERS
210HypoperfusionFAERS: 7US FAERS
211HypophagiaFAERS: 7US FAERS
212Inappropriate schedule of drug administrationFAERS: 7US FAERS
213PolyhydramniosFAERS: 7US FAERS
214PresyncopeFAERS: 7US FAERS
215Renal tubular necrosisFAERS: 7US FAERS
216Ventricular FibrillationFAERS: 7US FAERS
217Ventricular arrhythmiaFAERS: 7US FAERS
218APACHE II scoreFAERS: 6US FAERS
219Accidental exposure to productFAERS: 6US FAERS
220Activities of daily living impairedFAERS: 6US FAERS
221Acute Coronary SyndromeFAERS: 6US FAERS
222AgeusiaFAERS: 6US FAERS
223ApathyFAERS: 6US FAERS
224Apparent deathFAERS: 6US FAERS
225Autoimmune hepatitisFAERS: 6US FAERS
226Blood alkaline phosphatase increasedFAERS: 6US FAERS
227Depressed moodFAERS: 6US FAERS
228DermatitisFAERS: 6US FAERS
229EpilepsyFAERS: 6US FAERS
230Erectile dysfunctionFAERS: 6US FAERS
231HypocapniaFAERS: 6US FAERS
232Intentional product use issueFAERS: 6US FAERS
233Lip swellingFAERS: 6US FAERS
234Mental impairmentFAERS: 6US FAERS
235MicrocephalyFAERS: 6US FAERS
236Musculoskeletal PainFAERS: 6US FAERS
237PO2 increasedFAERS: 6US FAERS
238PetechiaeFAERS: 6US FAERS
239Product packaging issueFAERS: 6US FAERS
240Product size issueFAERS: 6US FAERS
241ProteinuriaFAERS: 6US FAERS
242ThirstFAERS: 6US FAERS
243Accidental drug intake by childFAERS: 5US FAERS
244AngerFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
245ArteriosclerosisFAERS: 5US FAERS
246ArthritisFAERS: 5US FAERS
247Blood pH abnormalFAERS: 5US FAERS
248CachexiaFAERS: 5US FAERS
249Cardiovascular insufficiencyFAERS: 5US FAERS
250CellulitisFAERS: 5US FAERS
251Circumstance or information capable of leading to medication errorFAERS: 5US FAERS
252Coronary Artery DiseaseFAERS: 5US FAERS
253CyanosisFAERS: 5US FAERS
254Deficiency of bile secretionFAERS: 5US FAERS
255Drug resistanceFAERS: 5US FAERS
256Gamma-Glutamyltransferase IncreasedFAERS: 5US FAERS
257Gestational DiabetesFAERS: 5US FAERS
258HypokinesiaFAERS: 5US FAERS
259InfluenzaFAERS: 5US FAERS
260Irritable Bowel SyndromeFAERS: 5US FAERS
261OligohydramniosFAERS: 5US FAERS
262PCO2 decreasedFAERS: 5US FAERS
263Product contaminationFAERS: 5US FAERS
264Product residue presentFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
265Product shape issueFAERS: 5US FAERS
266PseudoporphyriaFAERS: 5US FAERS
267Renal painFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
268RestlessnessFAERS: 5US FAERS
269SinusitisFAERS: 5US FAERS
270Systemic Inflammatory Response SyndromeFAERS: 5US FAERS
271Therapy non-responderFAERS: 5US FAERS
272Urinary RetentionFAERS: 5US FAERS
273Vitello-intestinal duct remnantFAERS: 5US FAERS
274APACHE II score increasedFAERS: 4US FAERS
275AbasiaFAERS: 4US FAERS
276Acute prerenal failureFAERS: 4US FAERS
277Acute respiratory failureFAERS: 4US FAERS
278Anorexia NervosaFAERS: 4US FAERS
279ArthropathyFAERS: 4US FAERS
280Blood alcohol increasedFAERS: 4US FAERS
281Blood creatine increasedFAERS: 4US FAERS
282Blood phosphorus decreasedFAERS: 4US FAERS
283Blood thyroid stimulating hormone decreasedFAERS: 4US FAERS
284Blood triglycerides increasedFAERS: 4US FAERS
285ChromaturiaFAERS: 4US FAERS
286CryingFAERS: 4US FAERS
287Drug screen false positiveFAERS: 4US FAERS
288Economic problemFAERS: 4US FAERS
289Ectopic PregnancyFAERS: 4US FAERS
290Foreign body traumaFAERS: 4US FAERS
291Grief reactionFAERS: 4US FAERS
292HemiparesisFAERS: 4US FAERS
293HepatomegalyFAERS: 4US FAERS
294IncoherentFAERS: 4US FAERS
295Lobar PneumoniaFAERS: 4US FAERS
296MalnutritionFAERS: 4US FAERS
297MenorrhagiaFAERS: 4US FAERS
298Multiple PregnancyFAERS: 4US FAERS
299Musculoskeletal stiffnessFAERS: 4US FAERS
300MyoclonusFAERS: 4US FAERS
301MyopathyFAERS: 4US FAERS
302Nerve injuryFAERS: 4US FAERS
303Oral painFAERS: 4US FAERS
304Oropharyngeal painFAERS: 4US FAERS
305PallorFAERS: 4US FAERS
306Palpable purpuraFAERS: 4US FAERS
307Pericardial effusionFAERS: 4US FAERS
308Portal HypertensionFAERS: 4US FAERS
309Prescribed overdoseFAERS: 4US FAERS
310Prescription drug used without a prescriptionFAERS: 4US FAERS
311Product counterfeitFAERS: 4US FAERS
312Product dispensing errorFAERS: 4US FAERS
313Product measured potency issueFAERS: 4US FAERS
314PsoriasisFAERS: 4US FAERS
315SluggishnessFAERS: 4US FAERS
316SneezingFAERS: 4US FAERS
317SuperinfectionFAERS: 4US FAERS
318Throat irritationFAERS: 4US FAERS
319Transaminases increasedFAERS: 4US FAERS
320WheezingFAERS: 4US FAERS
321Wrong technique in drug usage processFAERS: 4US FAERS
322AdactylyFAERS: 3US FAERS
323Agitated depressionFAERS: 3US FAERS
324Anion GapFAERS: 3US FAERS
325AortitisFAERS: 3US FAERS
326Aplasia Cutis CongenitaFAERS: 3US FAERS
327AscitesFAERS: 3US FAERS
328AsphyxiaFAERS: 3US FAERS
329Base excess decreasedFAERS: 3US FAERS
330Blood amylase increasedFAERS: 3US FAERS
331Blood cholesterol increasedFAERS: 3US FAERS
332Blood lactate dehydrogenase increasedFAERS: 3US FAERS
333Blood pressure fluctuationFAERS: 3US FAERS
334Blood pressure immeasurableFAERS: 3US FAERS
335Bone painFAERS: 3US FAERS
336BronchitisFAERS: 3US FAERS
337Carpal Tunnel SyndromeFAERS: 3US FAERS
338Cerebral disorderFAERS: 3US FAERS
339CholecystitisFAERS: 3US FAERS
340Coagulation time shortenedFAERS: 3US FAERS
341Cold sweatFAERS: 3US FAERS
342Contraindicated product administeredFAERS: 3US FAERS
343Craniofacial DysostosisFAERS: 3US FAERS
344Diabetic metabolic decompensationFAERS: 3US FAERS
345DiverticulitisFAERS: 3US FAERS
346Dry skinFAERS: 3US FAERS
347DysuriaFAERS: 3US FAERS
348Electrolyte imbalanceFAERS: 3US FAERS
349Emotional disorderFAERS: 3US FAERS
350EnterocolitisFAERS: 3US FAERS
351EosinophiliaFAERS: 3US FAERS
352Epigastric discomfortFAERS: 3US FAERS
353Flank PainFAERS: 3US FAERS
354General physical condition abnormalFAERS: 3US FAERS
355Hormone level abnormalFAERS: 3US FAERS
356HungerFAERS: 3US FAERS
357HydronephrosisFAERS: 3US FAERS
358HyperchlorhydriaFAERS: 3US FAERS
359Hyperdynamic left ventricleFAERS: 3US FAERS
360Hypertrophic CardiomyopathyFAERS: 3US FAERS
361HypospadiasFAERS: 3US FAERS
362HypoventilationFAERS: 3US FAERS
363Incorrect route of drug administrationFAERS: 3US FAERS
364Insulin ResistanceFAERS: 3US FAERS
365Intestinal infarctionFAERS: 3US FAERS
366Joint stiffnessFAERS: 3US FAERS
367KetosisFAERS: 3US FAERS
368Maternal exposure timing unspecifiedFAERS: 3US FAERS
369Muscle tightnessFAERS: 3US FAERS
370NasopharyngitisFAERS: 3US FAERS
371Nephrotic SyndromeFAERS: 3US FAERS
372NeuralgiaFAERS: 3US FAERS
373Neurological decompensationFAERS: 3US FAERS
374Night sweatsFAERS: 3US FAERS
375Nonspecific reactionFAERS: 3US FAERS
376ObesityFAERS: 3US FAERS
377Pancreatic CystFAERS: 3US FAERS
378PeriarthritisFAERS: 3US FAERS
379Poor quality drug administeredFAERS: 3US FAERS
380Post procedural complicationFAERS: 3US FAERS
381Product physical issueFAERS: 3US FAERS
382Product use complaintFAERS: 3US FAERS
383Protein urine presentFAERS: 3US FAERS
384PurpuraFAERS: 3US FAERS
385RalesFAERS: 3US FAERS
386Reaction to drug excipientsFAERS: 3US FAERS
387Respiratory DepressionFAERS: 3US FAERS
388StressFAERS: 3US FAERS
389Toxic Epidermal NecrolysisFAERS: 3US FAERS
390UlcerFAERS: 3US FAERS
391Umbilical malformationFAERS: 3US FAERS
392Urachal abnormalityFAERS: 3US FAERS
393Urinary IncontinenceFAERS: 3US FAERS
394Urinary tract obstructionFAERS: 3US FAERS
395Urine albumin/creatinine ratio abnormalFAERS: 3US FAERS
396Wrong drug administeredFAERS: 3US FAERS
397Wrong product administeredFAERS: 3US FAERS
398pseudomembranous colitisFAERS: 3US FAERS
399Abdominal massFAERS: 2US FAERS
400Abdominal symptomFAERS: 2US FAERS
401AcneFAERS: 2US FAERS
402Alanine aminotransferase abnormalFAERS: 2US FAERS
403Alcohol abuseFAERS: 2US FAERS
404Alcohol interactionFAERS: 2US FAERS
405Anaphylactoid ReactionFAERS: 2US FAERS
406Angular cheilitisFAERS: 2US FAERS
407AnhedoniaFAERS: 2US FAERS
408Arterial graftFAERS: 2US FAERS
409Aspartate aminotransferase abnormalFAERS: 2US FAERS
410BereavementFAERS: 2US FAERS
411Bipolar DisorderFAERS: 2US FAERS
412Blood albumin decreasedFAERS: 2US FAERS
413Blood chloride increasedFAERS: 2US FAERS
414Blood creatinine decreasedFAERS: 2US FAERS
415Blood homocysteine increasedFAERS: 2US FAERS
416Blood iron decreasedFAERS: 2US FAERS
417Blood magnesium increasedFAERS: 2US FAERS
418Blood sodium increasedFAERS: 2US FAERS
419Blood urea nitrogen/creatinine ratio increasedFAERS: 2US FAERS
420Breech PresentationFAERS: 2US FAERS
421Bronchial ObstructionFAERS: 2US FAERS
422CandidiasisFAERS: 2US FAERS
423Capillary Leak SyndromeFAERS: 2US FAERS
424Carbon dioxide decreasedFAERS: 2US FAERS
425Cardiac FlutterFAERS: 2US FAERS
426Cataract operationFAERS: 2US FAERS
427Cerebral InfarctionFAERS: 2US FAERS
428Choking sensationFAERS: 2US FAERS
429ClinodactylyFAERS: 2US FAERS
430Clostridium difficile colitisFAERS: 2US FAERS
431Clostridium difficile infectionFAERS: 2US FAERS
432ColectomyFAERS: 2US FAERS
433Congenital diaphragmatic herniaFAERS: 2US FAERS
434Conjunctival pallorFAERS: 2US FAERS
435ConjunctivitisFAERS: 2US FAERS
436Contact lens intoleranceFAERS: 2US FAERS
437Crystal urine presentFAERS: 2US FAERS
438CystitisFAERS: 2US FAERS
439Cytolytic hepatitisFAERS: 2US FAERS
440DementiaFAERS: 2US FAERS
441Diabetic RetinopathyFAERS: 2US FAERS
442Diaphragmatic HerniaFAERS: 2US FAERS
443DiplopiaFAERS: 2US FAERS
444Disease complicationFAERS: 2US FAERS
445Drug ToleranceFAERS: 2US FAERS
446EcchymosisFAERS: 2US FAERS
447EczemaFAERS: 2US FAERS
448Electrocardiogram abnormalFAERS: 2US FAERS
449Electrocardiogram changeFAERS: 2US FAERS
450Electrocardiogram repolarisation abnormalityFAERS: 2US FAERS
451Enterobacter test positiveFAERS: 2US FAERS
452ErysipelasFAERS: 2US FAERS
453Erythema MultiformeFAERS: 2US FAERS
454Escherichia test positiveFAERS: 2US FAERS
455Expired product administeredFAERS: 2US FAERS
456Extra dose administeredFAERS: 2US FAERS
457Eye irritationFAERS: 2US FAERS
458Facial PainFAERS: 2US FAERS
459Feeling jitteryFAERS: 2US FAERS
460Fixed eruptionFAERS: 2US FAERS
461Floppy iris syndromeFAERS: 2US FAERS
462Food PoisoningFAERS: 2US FAERS
463FractureFAERS: 2US FAERS
464Gastrointestinal PainFAERS: 2US FAERS
465Glasgow coma scale abnormalFAERS: 2US FAERS
466GlaucomaFAERS: 2US FAERS
467GlycosuriaFAERS: 2US FAERS
468GoutFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
469HemiplegiaFAERS: 2US FAERS
470Hepatitis CFAERS: 2US FAERS
471HypersomniaFAERS: 2US FAERS
472HyperthyroidismFAERS: 2US FAERS
473HypogeusiaFAERS: 2US FAERS
474HyporeflexiaFAERS: 2US FAERS
475HypothyroidismFAERS: 2US FAERS
476Impaired driving abilityFAERS: 2US FAERS
477Inability to afford medicationFAERS: 2US FAERS
478Incorrect product storageFAERS: 2US FAERS
479Incorrect storage of drugFAERS: 2US FAERS
480Intentional dose omissionFAERS: 2US FAERS
481Intentional self-injuryFAERS: 2US FAERS
482Intercepted drug dispensing errorFAERS: 2US FAERS
483Lactose IntoleranceFAERS: 2US FAERS
484LeukopeniaFAERS: 2US FAERS
485Lichen PlanusFAERS: 2US FAERS
486Limb discomfortFAERS: 2US FAERS
487Liver AbscessFAERS: 2US FAERS
488Low birth weight babyFAERS: 2US FAERS
489Lower respiratory tract infectionFAERS: 2US FAERS
490LymphadenopathyFAERS: 2US FAERS
491MacroglossiaFAERS: 2US FAERS
492MetrorrhagiaFAERS: 2US FAERS
493Mood swingsFAERS: 2US FAERS
494Muscle CrampFAERS: 2US FAERS
495Myoglobin blood increasedFAERS: 2US FAERS
496Neck PainFAERS: 2US FAERS
497NecrosisFAERS: 2US FAERS
498Neutrophil hypersegmented morphology presentFAERS: 2US FAERS
499NocturiaFAERS: 2US FAERS
500OnychoclasisFAERS: 2US FAERS
501Ovarian Hyperstimulation SyndromeFAERS: 2US FAERS
502Overlap syndromeFAERS: 2US FAERS
503Pelvic PainFAERS: 2US FAERS
504Pharmaceutical product counterfeitFAERS: 2US FAERS
505PneumonitisFAERS: 2US FAERS
506PolydipsiaFAERS: 2US FAERS
507PolyneuropathyFAERS: 2US FAERS
508Portal Vein ThrombosisFAERS: 2US FAERS
509Potentiating drug interactionFAERS: 2US FAERS
510Pregnancy test false positiveFAERS: 2US FAERS
511Product coating issueFAERS: 2US FAERS
512Productive CoughFAERS: 2US FAERS
513Protein S decreasedFAERS: 2US FAERS
514Protein total increasedFAERS: 2US FAERS
515PseudocystFAERS: 2US FAERS
516Pulmonary HypertensionFAERS: 2US FAERS
517Pulmonary InfarctionFAERS: 2US FAERS
518Pulmonary necrosisFAERS: 2US FAERS
519RadiculopathyFAERS: 2US FAERS
520Rash erythematousFAERS: 2US FAERS
521Renal Replacement TherapyFAERS: 2US FAERS
522ScabFAERS: 2US FAERS
523Sexual DysfunctionFAERS: 2US FAERS
524Shoulder DystociaFAERS: 2US FAERS
525Sinus bradycardiaFAERS: 2US FAERS
526Skin UlcerFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
527Skin lesionFAERS: 2US FAERS
528StarvationFAERS: 2US FAERS
529Stevens-Johnson SyndromeFAERS: 2US FAERS
530StomatitisFAERS: 2US FAERS
531Stool analysis abnormalFAERS: 2US FAERS
532Streptococcus test positiveFAERS: 2US FAERS
533StuporFAERS: 2US FAERS
534Sudden deathFAERS: 2US FAERS
535TalipesFAERS: 2US FAERS
536Therapeutic product contaminationFAERS: 2US FAERS
537Thyroid NeoplasmFAERS: 2US FAERS
538ToothacheFAERS: 2US FAERS
539Troponin increasedFAERS: 2US FAERS
540Urine ketone body presentFAERS: 2US FAERS
541Viral load increasedFAERS: 2US FAERS
542Visceral congestionFAERS: 2US FAERS
543Vulvovaginal painFAERS: 2US FAERS
544Acanthosis NigricansFAERS: 1US FAERS
545Accidental exposure to product by childFAERS: 1US FAERS
546Actinic keratosisFAERS: 1US FAERS
547Acute Lung InjuryFAERS: 1US FAERS
548AgranulocytosisFAERS: 1US FAERS
549Alanine aminotransferase decreasedFAERS: 1US FAERS
550Alcohol poisoningFAERS: 1US FAERS
551Altered visual depth perceptionFAERS: 1US FAERS
552AlveolitisFAERS: 1US FAERS
553Ammonia increasedFAERS: 1US FAERS
554AngioplastyFAERS: 1US FAERS
555AnisocytosisFAERS: 1US FAERS
556Ankle FractureFAERS: 1US FAERS
557AnosmiaFAERS: 1US FAERS
558Apallic syndromeFAERS: 1US FAERS
559AphagiaFAERS: 1US FAERS
560Aphthous StomatitisFAERS: 1US FAERS
561AppendicitisFAERS: 1US FAERS
562AtaxiaFAERS: 1US FAERS
563Atrial FlutterFAERS: 1US FAERS
564Atrioventricular BlockFAERS: 1US FAERS
565Autoimmune thyroiditisFAERS: 1US FAERS
566Band neutrophil percentage increasedFAERS: 1US FAERS
567Base excess increasedFAERS: 1US FAERS
568BedriddenFAERS: 1US FAERS
569Biliary ColicFAERS: 1US FAERS
570Bilirubin conjugated increasedFAERS: 1US FAERS
571Bipolar I disorderFAERS: 1US FAERS
572Bladder painFAERS: 1US FAERS
573Blood GlucoseFAERS: 1US FAERS
574Blood cortisol increasedFAERS: 1US FAERS
575Blood electrolytes decreasedFAERS: 1US FAERS
576Blood folate decreasedFAERS: 1US FAERS
577Blood ketone body increasedFAERS: 1US FAERS
578Blood lactic acidFAERS: 1US FAERS
579Blood osmolarity increasedFAERS: 1US FAERS
580Blood parathyroid hormone increasedFAERS: 1US FAERS
581Blood testosterone abnormalFAERS: 1US FAERS
582BradykinesiaFAERS: 1US FAERS
583BradyphreniaFAERS: 1US FAERS
584Brain DeathFAERS: 1US FAERS
585Breast discomfortFAERS: 1US FAERS
586Breast engorgementFAERS: 1US FAERS
587Breast tendernessFAERS: 1US FAERS
588BronchiolitisFAERS: 1US FAERS
589Cardiac DeathFAERS: 1US FAERS
590Cardiac function test abnormalFAERS: 1US FAERS
591CardiomegalyFAERS: 1US FAERS
592ChondrectomyFAERS: 1US FAERS
593ChorioamnionitisFAERS: 1US FAERS
594Chronic gastritisFAERS: 1US FAERS
595ClonusFAERS: 1US FAERS
596Clostridium test positiveFAERS: 1US FAERS
597ClumsinessFAERS: 1US FAERS
598Cluster HeadacheFAERS: 1US FAERS
599Coagulation factor VII level decreasedFAERS: 1US FAERS
600Coma acidoticFAERS: 1US FAERS
601Concomitant disease aggravatedFAERS: 1US FAERS
602Contraindicated drug administeredFAERS: 1US FAERS
603Creatinine renal clearance increasedFAERS: 1US FAERS
604Deafness NeurosensoryFAERS: 1US FAERS
605DeafnessFAERS: 1US FAERS
606DemyelinationFAERS: 1US FAERS
607Device dislocationFAERS: 1US FAERS
608Device related infectionFAERS: 1US FAERS
609Diabetic FootFAERS: 1US FAERS
610Diabetic foot infectionFAERS: 1US FAERS
611Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
612Diffuse large B-cell lymphoma recurrentFAERS: 1US FAERS
613Disease recurrenceFAERS: 1US FAERS
614DiverticulumFAERS: 1US FAERS
615Double ureterFAERS: 1US FAERS
616Drug clearance decreasedFAERS: 1US FAERS
617Drug effect delayedFAERS: 1US FAERS
618Drug screen positiveFAERS: 1US FAERS
619Drug withdrawal syndromeFAERS: 1US FAERS
620DysbacteriosisFAERS: 1US FAERS
621DysmorphismFAERS: 1US FAERS
622DysphoniaFAERS: 1US FAERS
623DystoniaFAERS: 1US FAERS
624Ear discomfortFAERS: 1US FAERS
625Early satietyFAERS: 1US FAERS
626Ejection Fraction DecreasedFAERS: 1US FAERS
627Electrocardiogram T wave peakedFAERS: 1US FAERS
628Electroconvulsive TherapyFAERS: 1US FAERS
629Electromechanical dissociationFAERS: 1US FAERS
630Emotional distressFAERS: 1US FAERS
631Endometrial adenocarcinomaFAERS: 1US FAERS
632EnteritisFAERS: 1US FAERS
633Enzyme level increasedFAERS: 1US FAERS
634Escherichia infectionFAERS: 1US FAERS
635Essential HypertensionFAERS: 1US FAERS
636Expired drug administeredFAERS: 1US FAERS
637Exposure via breast milkFAERS: 1US FAERS
638Extracorporeal Membrane OxygenationFAERS: 1US FAERS
639Eye painFAERS: 1US FAERS
640Eyeglasses therapyFAERS: 1US FAERS
641Eyelid margin crustingFAERS: 1US FAERS
642Factor VII DeficiencyFAERS: 1US FAERS
643False positive investigation resultFAERS: 1US FAERS
644Febrile NeutropeniaFAERS: 1US FAERS
645Feeling of body temperature changeFAERS: 1US FAERS
646FibrosisFAERS: 1US FAERS
647Fluid overloadFAERS: 1US FAERS
648Foaming at mouthFAERS: 1US FAERS
649Food AllergyFAERS: 1US FAERS
650Food aversionFAERS: 1US FAERS
651Food cravingFAERS: 1US FAERS
652Foreign body aspirationFAERS: 1US FAERS
653Foreign body in respiratory tractFAERS: 1US FAERS
654FormicationFAERS: 1US FAERS
655FrustrationFAERS: 1US FAERS
656Gait inabilityFAERS: 1US FAERS
657Gallbladder painFAERS: 1US FAERS
658GangreneFAERS: 1US FAERS
659Gastric BypassFAERS: 1US FAERS
660Gastric DilatationFAERS: 1US FAERS
661GastroduodenitisFAERS: 1US FAERS
662Gastrointestinal inflammationFAERS: 1US FAERS
663Gastrointestinal motility disorderFAERS: 1US FAERS
664Gastrointestinal mucosal disorderFAERS: 1US FAERS
665Gastrointestinal stoma output increasedFAERS: 1US FAERS
666Gastrointestinal stromal cancerFAERS: 1US FAERS
667Gaze palsyFAERS: 1US FAERS
668Granuloma AnnulareFAERS: 1US FAERS
669Head discomfortFAERS: 1US FAERS
670Heart sounds abnormalFAERS: 1US FAERS
671Hepatic EncephalopathyFAERS: 1US FAERS
672Hip surgeryFAERS: 1US FAERS
673HyperphagiaFAERS: 1US FAERS
674HyperpyrexiaFAERS: 1US FAERS
675Hypoaesthesia facialFAERS: 1US FAERS
676HypotrichosisFAERS: 1US FAERS
677Impaired gastric emptyingFAERS: 1US FAERS
678Inappropriate schedule of product administrationFAERS: 1US FAERS
679IncontinenceFAERS: 1US FAERS
680Incorrect drug dosage form administeredFAERS: 1US FAERS
681InfarctionFAERS: 1US FAERS
682Initial insomniaFAERS: 1US FAERS
683Insulin C-peptide decreasedFAERS: 1US FAERS
684Intercepted medication errorFAERS: 1US FAERS
685Intracranial AneurysmFAERS: 1US FAERS
686Iodine allergyFAERS: 1US FAERS
687Iron deficiencyFAERS: 1US FAERS
688LacerationFAERS: 1US FAERS
689Lactation DisorderFAERS: 1US FAERS
690Laryngeal ObstructionFAERS: 1US FAERS
691Left Ventricular HypertrophyFAERS: 1US FAERS
692LeukoencephalopathyFAERS: 1US FAERS
693Limb injuryFAERS: 1US FAERS
694Lipase increasedFAERS: 1US FAERS
695Lipids abnormalFAERS: 1US FAERS
696Livedo ReticularisFAERS: 1US FAERS
697Loss of personal independence in daily activitiesFAERS: 1US FAERS
698Low set earsFAERS: 1US FAERS
699Lupus-like syndromeFAERS: 1US FAERS
700LymphomaFAERS: 1US FAERS
701Macular degenerationFAERS: 1US FAERS
702Macular opacityFAERS: 1US FAERS
703Maternal exposure before pregnancyFAERS: 1US FAERS
704Mechanical ventilationFAERS: 1US FAERS
705Medical device complicationFAERS: 1US FAERS
706MenopauseFAERS: 1US FAERS
707Metabolic alkalosisFAERS: 1US FAERS
708Metastatic NeoplasmFAERS: 1US FAERS
709MicroalbuminuriaFAERS: 1US FAERS
710Micturition frequency decreasedFAERS: 1US FAERS
711Middle insomniaFAERS: 1US FAERS
712Mixed liver injuryFAERS: 1US FAERS
713MonoplegiaFAERS: 1US FAERS
714Multi-organ disorderFAERS: 1US FAERS
715Multiple drug overdoseFAERS: 1US FAERS
716Multiple drug overdose intentionalFAERS: 1US FAERS
717Muscle FatigueFAERS: 1US FAERS
718Muscle strainFAERS: 1US FAERS
719Musculoskeletal chest painFAERS: 1US FAERS
720Myasthenia GravisFAERS: 1US FAERS
721MyelitisFAERS: 1US FAERS
722Neonatal diabetes mellitusFAERS: 1US FAERS
723Neonatal infectionFAERS: 1US FAERS
724NephrectomyFAERS: 1US FAERS
725Neutrophil percentage increasedFAERS: 1US FAERS
726No adverse effectFAERS: 1US FAERS
727NystagmusFAERS: 1US FAERS
728ObstructionFAERS: 1US FAERS
729OnycholysisFAERS: 1US FAERS
730Oral infectionFAERS: 1US FAERS
731OsteitisFAERS: 1US FAERS
732OsteomyelitisFAERS: 1US FAERS
733OsteoporosisFAERS: 1US FAERS
734Ovarian RuptureFAERS: 1US FAERS
735PO2 abnormalFAERS: 1US FAERS
736Pancreatic PseudocystFAERS: 1US FAERS
737Pancreatic enzymes increasedFAERS: 1US FAERS
738Paradoxical drug reactionFAERS: 1US FAERS
739Paranasal sinus hypersecretionFAERS: 1US FAERS
740ParaparesisFAERS: 1US FAERS
741Patient IsolationFAERS: 1US FAERS
742Pelvic massFAERS: 1US FAERS
743Penile curvatureFAERS: 1US FAERS
744PericarditisFAERS: 1US FAERS
745Peripartum cardiomyopathyFAERS: 1US FAERS
746Peripheral arterial occlusive diseaseFAERS: 1US FAERS
747Peripheral venous diseaseFAERS: 1US FAERS
748Perivascular dermatitisFAERS: 1US FAERS
749Personality ChangeFAERS: 1US FAERS
750Petroleum distillate poisoningFAERS: 1US FAERS
751Pharyngolaryngeal PainFAERS: 1US FAERS
752PhotophobiaFAERS: 1US FAERS
753PleurisyFAERS: 1US FAERS
754PneumothoraxFAERS: 1US FAERS
755Poor quality sleepFAERS: 1US FAERS
756Post procedural sepsisFAERS: 1US FAERS
757Pre-EclampsiaFAERS: 1US FAERS
758Precancerous skin lesionFAERS: 1US FAERS
759Prerenal failureFAERS: 1US FAERS
760Procedural complicationFAERS: 1US FAERS
761Procedural nauseaFAERS: 1US FAERS
762Procedural vomitingFAERS: 1US FAERS
763Product contamination physicalFAERS: 1US FAERS
764Product difficult to swallowFAERS: 1US FAERS
765Product dispensing issueFAERS: 1US FAERS
766Product dosage form issueFAERS: 1US FAERS
767Product label issueFAERS: 1US FAERS
768Product prescribing errorFAERS: 1US FAERS
769Product storage errorFAERS: 1US FAERS
770Product tamperingFAERS: 1US FAERS
771Protein total decreasedFAERS: 1US FAERS
772Prothrombin level decreasedFAERS: 1US FAERS
773Pulmonary congestionFAERS: 1US FAERS
774Pulmonary function test decreasedFAERS: 1US FAERS
775PurulenceFAERS: 1US FAERS
776Purulent dischargeFAERS: 1US FAERS
777RadiculitisFAERS: 1US FAERS
778Reaction to excipientFAERS: 1US FAERS
779Rectal tenesmusFAERS: 1US FAERS
780Renal ColicFAERS: 1US FAERS
781Renal abscessFAERS: 1US FAERS
782Renal tubular disorderFAERS: 1US FAERS
783Renal tubular injuryFAERS: 1US FAERS
784Retroperitoneal fibrosisFAERS: 1US FAERS
785Ruptured ectopic pregnancyFAERS: 1US FAERS
786SciaticaFAERS: 1US FAERS
787Self-induced vomitingFAERS: 1US FAERS
788Serotonin SyndromeFAERS: 1US FAERS
789Single functional kidneyFAERS: 1US FAERS
790Sinus headacheFAERS: 1US FAERS
791Skin cosmetic procedureFAERS: 1US FAERS
792Skin reactionFAERS: 1US FAERS
793Sleep TalkingFAERS: 1US FAERS
794Spinal column stenosisFAERS: 1US FAERS
795Spinal cord herniationFAERS: 1US FAERS
796Squamous cell carcinomaFAERS: 1US FAERS
797Staphylococcus test positiveFAERS: 1US FAERS
798Status EpilepticusFAERS: 1US FAERS
799Strangulated herniaFAERS: 1US FAERS
800StridorFAERS: 1US FAERS
801Supraventricular tachycardiaFAERS: 1US FAERS
802Tablet physical issueFAERS: 1US FAERS
803Temperature intoleranceFAERS: 1US FAERS
804Tethered Cord SyndromeFAERS: 1US FAERS
805Therapeutic product effect decreasedFAERS: 1US FAERS
806Therapeutic response changedFAERS: 1US FAERS
807Therapeutic response unexpectedFAERS: 1US FAERS
808Thermal burnFAERS: 1US FAERS
809ThrombocytosisFAERS: 1US FAERS
810Thyroid cancer stage IFAERS: 1US FAERS
811Tooth LossFAERS: 1US FAERS
812Tooth repairFAERS: 1US FAERS
813Toxic dilatation of intestineFAERS: 1US FAERS
814Toxicologic test abnormalFAERS: 1US FAERS
815Transcription medication errorFAERS: 1US FAERS
816Transferrin increasedFAERS: 1US FAERS
817TrichorrhexisFAERS: 1US FAERS
818Trigeminal NeuralgiaFAERS: 1US FAERS
819TrismusFAERS: 1US FAERS
820Unexpected therapeutic drug effectFAERS: 1US FAERS
821Upper-airway cough syndromeFAERS: 1US FAERS
822UreterolithiasisFAERS: 1US FAERS
823Urine bilirubin increasedFAERS: 1US FAERS
824Urine output increasedFAERS: 1US FAERS
825Uterine CancerFAERS: 1US FAERS
826Uterine ObstructionFAERS: 1US FAERS
827Venous occlusionFAERS: 1US FAERS
828Venous oxygen partial pressure increasedFAERS: 1US FAERS
829Ventricular hypokinesiaFAERS: 1US FAERS
830Vibration test abnormalFAERS: 1US FAERS
831Vitamin B12 absorption test abnormalFAERS: 1US FAERS
832VitiligoFAERS: 1US FAERS
833Vitreous fibrinFAERS: 1US FAERS
834Von Willebrand's factor antigen increasedFAERS: 1US FAERS
835Vulvovaginal burning sensationFAERS: 1US FAERS
836Vulvovaginal discomfortFAERS: 1US FAERS
837White blood cell count decreasedFAERS: 1US FAERS
838Wolff-Parkinson-White SyndromeFAERS: 1US FAERS
839Wound InfectionFAERS: 1US FAERS
840XanthopsiaFAERS: 1US FAERS
841furuncleFAERS: 1US FAERS
842insulinomaFAERS: 1US FAERS
843pH body fluid decreasedFAERS: 1US FAERS
844prostatitisFAERS: 1US FAERS
845Blood osmolarity decreasedCanada Vigilance: 1Canada Vigilance
846Bowel movement irregularityCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.